Litigation Details for Novartis Pharmaceuticals Corporation v. Crystal Pharmaceutical (Suzhou) Co., Ltd. (D. Del. 2021)
✉ Email this page to a colleague
Novartis Pharmaceuticals Corporation v. Crystal Pharmaceutical (Suzhou) Co., Ltd. (D. Del. 2021)
| Docket | ⤷ Sign Up | Date Filed | 2021-09-24 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | |
| Jury Demand | None | Referred To | |
| Patents | 10,543,179; 8,101,659; 8,796,331; 8,877,938; 9,187,405; 9,388,134 | ||
| Link to Docket | External link to docket | ||
Details for Novartis Pharmaceuticals Corporation v. Crystal Pharmaceutical (Suzhou) Co., Ltd. (D. Del. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2022-07-14 | 33 | Redacted Document | Novartis filed yet another suit on U.S. Patent No. 10,543,179 in January of 2020. (20-133, D.I. 1, 3.…in a patent or the use of which is claimed in a patent before the expiration of such patent.” … relief can be granted.” The three patents in question—U.S. Patent Nos. 9,517,226; 9,937,143; and 11,…use of which is claimed in a patent before the expiration of such patent.” 35 U.S.C. § 271(e)(2). The… drug claimed in a patent or the use of which is claimed in a patent, … if the purpose of such | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
